Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Venous Thrombosis I: Introduction

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

Multiple Allele Traits

Multiple Allele Traits

The Concept of Multiple Allelism

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Thalassaemia.

Nature reviews. Disease primers·2026

Same author

Targeting ineffective erythropoiesis in thalassemia: biologic therapies and emerging therapeutic strategies.

Expert opinion on biological therapy·2026

Same author

Addressing Obstetric and Gynecologic Needs in Thalassemia.

O&G open·2026

Same author

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026

Same author

When cure exists but access does not.

Nature medicine·2026

Same author

Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.

European journal of haematology·2026

Search research articles

Related Experiment Video

Updated: May 22, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Hypercoagulability in non-transfusion-dependent thalassemia.

Maria D Cappellini¹, Khaled M Musallam, Erika Poggiali

¹IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, University of Milan, Via Francesco Sforza 35, Milan, Italy. maria.cappellini@unimi.it

|May 29, 2012

Summary

Beta-thalassemia patients face a higher risk of blood clots due to hypercoagulability. Managing this involves regular transfusions and avoiding splenectomy to reduce thrombosis and prevent serious health issues.

Related Experiment Videos

Last Updated: May 22, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

Area of Science:

Hematology
Vascular Biology
Thrombosis Research

Background:

Beta-thalassemia is associated with a hypercoagulable state, increasing thrombosis risk and leading to significant morbidity and mortality.
Mechanisms include platelet activation, altered red blood cell membranes, endothelial adhesion molecule changes, and hemostasis dysregulation.

Purpose of the Study:

To summarize the hypercoagulable state in beta-thalassemia.
To discuss factors influencing thrombosis risk, such as transfusions and splenectomy.
To recommend strategies for mitigating thrombosis risk.

Main Methods:

Literature review and analysis of existing data on beta-thalassemia pathophysiology.
Examination of molecular and cellular mechanisms of hypercoagulability.
Evaluation of the impact of therapeutic interventions on thrombosis risk.

Main Results:

Beta-thalassemia presents diverse molecular and cellular mechanisms contributing to hypercoagulability.
Regular transfusions reduce thrombosis risk, while splenectomy significantly increases it.
Splenectomized adults with non-transfusion-dependent thalassemia are at high risk for ischemic brain damage.

Conclusions:

Strategies to lower thrombosis risk in beta-thalassemia are crucial.
Transfusion therapy to maintain adequate hemoglobin levels is recommended.
Avoidance or delayed splenectomy is advised to minimize thrombosis risk.